Model
Edge
Alnylam Pharmaceuticals, Inc.
0001557290
Filing Type
3
Filing Date
1/6/2026
Updated
1/7/26, 2:16 PM
Filing
3
Earnings Release
Exhibits
3
Initial Statement of Beneficial Ownership